ANCOBON (Valeant Pharmaceuticals North America LLC)


Welcome to the PulseAid listing for the ANCOBON drug offered from Valeant Pharmaceuticals North America LLC. This Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antifungal [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Valeant Pharmaceuticals North America LLC
NON-PROPRIETARY NAME: Flucytosine
SUBSTANCE NAME: FLUCYTOSINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antifungal [EPC]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1971-11-26
END MARKETING DATE: 0000-00-00


ANCOBON HUMAN PRESCRIPTION DRUG Details:

Item DescriptionANCOBON from Valeant Pharmaceuticals North America LLC
LABELER NAME: Valeant Pharmaceuticals North America LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 250(mg/1)
START MARKETING DATE: 1971-11-26
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0187-3554_8c954cdd-efd0-470a-8093-0e5ce8fd5720
PRODUCT NDC: 0187-3554
APPLICATION NUMBER: NDA017001

Other FLUCYTOSINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalFlucytosine
Cameron Pharmaceuticals, LLCFlucytosine
Cardinal HealthAncobon
Carilion Materials ManagementFlucytosine
Rising Pharmaceuticals, Inc.Flucytosine
Valeant Pharmaceuticals North America LLCANCOBON
West-Ward Pharmaceuticals Corpflucytosine